Clinical Trials
6 trialsNCT03667170 2026-03-25
KN035 for dMMR/MSI-H Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
NCT04891198 2026-03-25
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
NCT04910386 2026-03-25
Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers
3D Medicines
Phase 2 Not yet recruiting
NCT05112991 2026-03-25
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
3D Medicines
Phase 2 Recruiting
NCT05068427 2024-08-07
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Chipscreen Biosciences, Ltd.
Phase 2 Completed
NCT04480502 2024-05-17
ENVASARC
Tracon Pharmaceuticals Inc.
Phase 2 Active not recruiting